RN

Roopali Nanjappa Kandarthanda

Active Director Designated Partner DIN 08053729
DIN 08053729 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Roopali Nanjappa Kandarthanda

Data last updated:

Roopali Nanjappa Kandarthanda is a Designated Partner at Cauvery Uroderm Llp (since 2018). The company operates in Healthcare.

DIN 08053729
Primary Designation Designated Partner
Industry Healthcare
First Appointment 24 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner24 Mar 20182018Active

Board colleagues of Roopali Nanjappa Kandarthanda

NameDINCompanyDesignation
Kandarthanda Madappa Nanjappa06908135Cauvery Uroderm LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cauvery Uroderm Llp
Premium access

Shareholding and investment profile for Roopali Nanjappa Kandarthanda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roopali Nanjappa Kandarthanda

Roopali Nanjappa Kandarthanda currently holds 1 directorship: Cauvery Uroderm Llp (Designated Partner, since 24 Mar 2018).

Roopali Nanjappa Kandarthanda was first appointed on 24 Mar 2018 as Designated Partner at Cauvery Uroderm Llp.

The current boards of Roopali Nanjappa Kandarthanda's companies include Kandarthanda Madappa Nanjappa (Cauvery Uroderm Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available